MinichMacGregor Wealth Management’s Amicus Therapeutics FOLD Stock Holding History

MinichMacGregor Wealth Management’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-610	Closed	-$7.45K	–	280
2022 Q4	$7.45K	Buy	+610	New	+$6.87K	﹤0.01%	439
2018 Q4	–	Sell	-1,613	Closed	-$20K	–	227
2018 Q3	$20K	Hold	1,613	–	–	0.01%	216
2018 Q2	$24K	Hold	1,613	–	–	0.02%	188
2018 Q1	$24K	Hold	1,613	–	–	0.02%	192
2017 Q4	$23K	Hold	1,613	–	–	0.02%	186
2017 Q3	$24K	Hold	1,613	–	–	0.02%	175
2017 Q2	$16K	Hold	1,613	–	–	0.01%	213
2017 Q1	$11K	Hold	1,613	–	–	0.01%	257
2016 Q4	$8K	Hold	1,613	–	–	0.01%	286
2016 Q3	$11K	Hold	1,613	–	–	0.01%	251
2016 Q2	$8K	Hold	1,613	–	–	0.01%	283
2016 Q1	$13K	Sell	1,613 -280	-15%	-$1.98K	0.01%	213
2015 Q4	$23K	Buy	+1,893	New	+$17.1K	0.02%	154

Other funds holding FOLD

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

MinichMacGregor Wealth Management's FOLD Position: Q1 2023 in Review

MinichMacGregor Wealth Management sold out of Amicus Therapeutics (FOLD) in Q1 2023, closing a stake of 610 shares — an estimated $7.45K sold.

MinichMacGregor Wealth Management first reported a position in FOLD in Q4 2015 and held it in 13 quarters. The position peaked at $24K in Q2 2018. 226 funds tracked by Wall St. Rank hold FOLD as of Q1 2023.

MinichMacGregor Wealth Management reported no remaining Amicus Therapeutics position as of Q1 2023 after selling out during the quarter.
MinichMacGregor Wealth Management sold 610 Amicus Therapeutics shares in Q1 2023, an estimated $7.45K.
MinichMacGregor Wealth Management first reported a position in Amicus Therapeutics in Q4 2015 and held it in 13 quarters.
MinichMacGregor Wealth Management's Amicus Therapeutics position peaked at $24K in Q2 2018.
226 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2023.

Based on MinichMacGregor Wealth Management's 13F filing for Q1 2023, filed 19 Apr 2023.